Securities Registration (section 12(b)) (8-a12b)
16 Septembre 2021 - 8:18PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-A
FOR
REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Ginkgo
Bioworks Holdings, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
87-2652913
|
(State of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
27 Drydock Avenue
8th Floor
Boston, MA
|
|
020110
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Securities to be registered pursuant to Section 12(b) of the Act:
|
|
|
Title for each class
to be so registered
|
|
Name of each exchange on which
each class is to be registered
|
|
|
Class A common stock, par value $0.0001 per share
|
|
The New York Stock Exchange
|
|
|
Warrants, each whole warrant exercisable to purchase one share of Class A common stock at an exercise price of $11.50 per share
|
|
The New York Stock Exchange
|
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), please check the following box. ☒
If this form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. ☐
Securities Act registration statement file number to which this form relates: (if applicable)
Securities to be registered pursuant to Section 12(g) of the Act: N/A
Explanatory Note
This Registration Statement on Form 8-A is being filed by Ginkgo Bioworks Holdings, Inc. (the
Company), formerly known as Soaring Eagle Acquisition Corp., with the U.S. Securities and Exchange Commission (the SEC) in connection with the transfer of the listing of the Companys Class A common stock, par value
$0.0001 per share (Company Common Stock), and its warrants to purchase shares of Company Common Stock (the Company Warrants) from the Nasdaq Capital Market (Nasdaq) to The New York Stock Exchange.
Item 1. Description of Registrants Securities to be Registered.
The securities to be registered hereby are the Company Common Stock and Company Warrants.
The description of the Company Warrants registered hereunder is set forth under the heading Description of Securities in the
prospectus, dated as of February 23, 2021 (File No.
333-251661) and filed with the SEC on February 25, 2021 and is incorporated herein by reference. The description of the Company
Common Stock registered hereunder is set forth under the heading Description of New Ginkgo Securities in the definitive proxy statement / prospectus, dated as of August 11, 2021 (File
No. 333-256121) and filed with the SEC on August 13, 2021, and is incorporated herein
by reference.
Item 2. Exhibits.
In accordance with the Instructions as to Exhibits with respect to Form 8-A, no exhibits
are required to be filed as part of this registration statement because no other securities of the registrant are registered on The New York Stock Exchange and the securities registered hereby are not being registered pursuant to Section 12(g)
of the Securities Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: September 16, 2021
|
|
|
Ginkgo Bioworks Holdings, Inc.
|
|
|
By:
|
|
/s/ Mark Dmytruk
|
|
|
Name: Mark Dmytruk
|
|
|
Title: Chief Financial Officer
|
Soaring Eagle Acquisition (NASDAQ:SRNG)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Soaring Eagle Acquisition (NASDAQ:SRNG)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024
Real-Time news about Soaring Eagle Acquisition Corporation (NASDAQ): 0 recent articles
Plus d'articles sur Soaring Eagle Acquisition Corp.